Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a report issued on Monday. The firm issued a hold rating on the medical device company’s stock.

Avinger Price Performance

AVGR opened at $0.80 on Monday. Avinger has a 1 year low of $0.39 and a 1 year high of $5.45. The company has a market capitalization of $2.66 million, a price-to-earnings ratio of -0.07 and a beta of 1.15. The firm’s fifty day moving average price is $0.80 and its two-hundred day moving average price is $1.07.

Avinger (NASDAQ:AVGR) last released its quarterly earnings results on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, topping the consensus estimate of ($2.03) by $0.21. The business had revenue of $1.65 million for the quarter, compared to analysts’ expectations of $1.60 million. Avinger had a negative net margin of 261.06% and a negative return on equity of 5,527.11%. During the same period in the previous year, the company earned ($2.92) earnings per share. As a group, equities analysts anticipate that Avinger will post -4.69 EPS for the current year.

Institutional Trading of Avinger

A hedge fund recently bought a new stake in Avinger stock. Armistice Capital LLC bought a new stake in shares of Avinger, Inc. (NASDAQ:AVGR) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 43,747 shares of the medical device company’s stock, valued at approximately $81,000. Armistice Capital LLC owned about 2.57% of Avinger at the end of the most recent reporting period. 18.30% of the stock is owned by institutional investors and hedge funds.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.